NCT05053204

Brief Summary

Cognitive impairment is the core symptom of unipolar and bipolar depression, which seriously affects the prognosis of the disease and the rehabilitation of social function. There is no unified conclusion in the field and severity of cognitive impairment, and the cause of cognitive impairment is unknown, which may be related to many factors. In this study,the THINC-it tool was used to study the characteristics of cognitive impairment in unipolar and bipolar depression by longitudinal follow-up, which provides a theoretical basis for the differential diagnosis of unipolar and bipolar depression. Early identification and intervention of risk factors can improve the prognosis of the disease.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 15, 2021

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

September 13, 2021

Completed
9 days until next milestone

First Posted

Study publicly available on registry

September 22, 2021

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2022

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2023

Completed
Last Updated

September 14, 2022

Status Verified

September 1, 2021

Enrollment Period

1.5 years

First QC Date

September 13, 2021

Last Update Submit

September 9, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • the THINC-it Tool

    The composite THINC-it tool score is the integrated total score of results from performance on five sub-component cognitive tests of the THINC-it tool.

    up to 12 week

Secondary Outcomes (3)

  • HAMD-17

    up to 12 week

  • HAM-A

    up to 12 week

  • Pittsburgh Sleep Quality Index,PSQI

    up to 12 week

Study Arms (3)

unipolar depression group

In accordance with the diagnostic criteria of ICD-10 Unipolar depressive disorder, outpatients or inpatients in the Department of mood Disorders, Mental Health Center of Pudong New area.

bipolar depression group

In accordance with the diagnostic criteria of ICD-10 Bipolar depression , outpatients or inpatients in the Department of mood Disorders, Mental Health Center of Pudong New area.

healthy control group

Any mental disorder that does not meet the diagnosis of ICD-10, and the society recruits healthy controls who match the sex, age and education level of the patients in the case-group.

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

According to the diagnostic criteria of ICD-10 Unipolar and bipolar depressive disorder, 40 patients with Major depressive disorder, 40 patients with bipolar depression and 40 healthy controls matched with the sex, age and education level of the patients in the case group served as healthy controls.

You may qualify if:

  • Case group:
  • 、Participants in psychiatric outpatients and inpatients are able and willing to provide informed consent.
  • \. The participants were male or female aged between 18 and 60, with junior high school education or above.
  • \. According to ICD-10 criteria, participants were diagnosed with Unipolar and bipolar depressive disorder.
  • \. The total score of Young's Mania scale ((YMRS)) of the participants was less than 5 and HAMD-17 was greater than17.
  • \. Subjects received stable mood stabilizers at least two weeks before the study visit, such as SSRIs antidepressants.
  • \. The combination or use of supportive psychotherapy is allowed.
  • Control group:
  • it did not meet any of the diagnostic criteria in ICD-10 in the past or at present.
  • years old, junior high school education or above. 3.Have sufficient audio-visual skills to complete the necessary examinations of the study.
  • Willing to participate in this study, and the informed consent form was signed by the subjects.

You may not qualify if:

  • Current alcohol and / or substance use disorders.
  • Any drugs that may affect cognitive function, such as psychotropic stimulants, corticosteroids, and receptor blockers.
  • Benzodiazepines were used within 12 hours and alcohol consumption within 8 hours before using the THINC-it tool.
  • The patients have some serious physical conditions.
  • The patients received electroconvulsive therapy ((ECT)) in the past 6 months.
  • They are serious negative suicidal concepts and behaviors.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai Mental Health Center IRB

Shanghai, Shanghai Municipality, 200030, China

RECRUITING

MeSH Terms

Conditions

Cognitive Dysfunction

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental Disorders

Study Officials

  • Jun Chen, M.D., Ph.D

    Shanghai Mental Health Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 13, 2021

First Posted

September 22, 2021

Study Start

May 15, 2021

Primary Completion

October 30, 2022

Study Completion

June 30, 2023

Last Updated

September 14, 2022

Record last verified: 2021-09

Locations